Precision Medicine in Pediatric Bithalamic Glioma: Significance of the EGFR exon 20 Insertion Mutation.

[1]  Xue Wu,et al.  Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors , 2020, Molecular oncology.

[2]  M. Berger,et al.  Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition , 2020, Acta Neuropathologica.

[3]  Paul H. Huang,et al.  Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer , 2019, Signal Transduction and Targeted Therapy.

[4]  Scott N. Hwang,et al.  Bithalamic gliomas may be molecularly distinct from their unilateral high‐grade counterparts , 2018, Brain pathology.

[5]  Yanhui Liu,et al.  Prognostic Factors for the Survival Outcome of Bilateral Thalamic Glioma: An Integrated Survival Analysis. , 2017, World neurosurgery.

[6]  J. Teo,et al.  Bilateral Thalamic and Right Fronto-temporo-parietal Gliomas in a 4 Years Old Child Diagnosed by Magnetic Resonance Imaging. , 2016, Journal of radiology case reports.

[7]  Geoffrey R. Oxnard,et al.  Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer , 2013, Science Translational Medicine.

[8]  W. Cavenee,et al.  Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. , 2012, Current cancer drug targets.

[9]  N. Boddaert,et al.  Thalamic tumors in children: a reappraisal. , 2007, Journal of neurosurgery.

[10]  T. Merchant,et al.  Bithalamic Involvement Predicts Poor Outcome among Children with Thalamic Glial Tumors , 1998, Pediatric Neurosurgery.